![](/img/cover-not-exists.png)
P.082 Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027)
M. Manns, D. Shouval, U.S. Akarca, G. Hatzis, G. Kitis, R. Zink, J. Zhu, H. Brett-SmithVolume:
36
Year:
2006
Language:
english
DOI:
10.1016/s1386-6532(06)80265-9
File:
PDF, 133 KB
english, 2006